glp 1 therapies GLP-1-based for diabetes, obesity and beyond GLP-1 Agonists: A Comprehensive Overview

As a scientist, its exciting to conduct research at this scaleusing millions of real-world data points to uncover measurable patterns and actionable insights

Once mechanical obstruction is excluded, gastric scintigraphy remains the gold standard for diagnosis although wireless motility capsule and breath testing are alternative methods for diagnosis

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.

Zepbound and Mounjaro have been shown to yield greater weight loss than Wegovy or Ozempic

This drug, indicated for glycemic control in patients aged 10 years and above with type 2 diabetes, serves as an adjunct to diet and exercise

Results Despite heterogeneity in study designs and populations, a largely consistent association was found between GLP-1RA use and a reduced incidence of glaucoma